The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-N-(3-hydroxypropoxy)benzamide ID: ALA4588064
PubChem CID: 10139826
Max Phase: Preclinical
Molecular Formula: C16H14F3IN2O3
Molecular Weight: 466.20
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NOCCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
Standard InChI: InChI=1S/C16H14F3IN2O3/c17-11-4-3-10(16(24)22-25-7-1-6-23)15(14(11)19)21-13-5-2-9(20)8-12(13)18/h2-5,8,21,23H,1,6-7H2,(H,22,24)
Standard InChI Key: PWJVGVUKOYIXGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
6.5898 -9.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5886 -10.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2967 -10.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0063 -10.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0035 -9.2785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2949 -8.8732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2965 -11.3278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0041 -11.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9997 -12.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7065 -12.9607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4153 -12.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4129 -11.7308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7055 -11.3258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8806 -10.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1732 -10.1005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8799 -11.3269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4652 -10.5086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4645 -11.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7565 -11.7338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7558 -12.5510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0478 -12.9590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2908 -12.9584 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.7147 -10.5086 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.7097 -8.8672 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.1235 -12.9600 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
2 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
9 22 1 0
4 23 1 0
5 24 1 0
11 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 466.20Molecular Weight (Monoisotopic): 466.0001AlogP: 3.50#Rotatable Bonds: 7Polar Surface Area: 70.59Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.99CX Basic pKa: ┄CX LogP: 4.67CX LogD: 4.67Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.33Np Likeness Score: -1.36
References 1. Bauer MR, Mackey MD.. (2019) Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes., 62 (6): [PMID:30807144 ] [10.1021/acs.jmedchem.8b01925 ]